Skip to main content
. Author manuscript; available in PMC: 2019 Sep 6.
Published in final edited form as: Muscle Nerve. 2018 Mar 6:10.1002/mus.26117. doi: 10.1002/mus.26117

Table 3. Responses of the 20 Participants by Treatment and Treatment Order.

Treatment Sequence No. of Patients Treatment
Placebo Mexiletine Reduction
Mean (SD) number cramps/d
 Placebo first 12 4.7 (4.2) 2.5 (2.8) 2.2 (2.2)
 Mexiletine first 8 6.1 (8.1) 4.9 (8.0) 1.2 (2.9)
Mean (SD) cramp severity/d, unita
 Placebo first 12 44.7 (26.7) 32.8 (27.7) 12.0 (18.1)
 Mexiletine first 8 43.6 (31.0) 23.1 (16.8) 20.5 (40.6)
Mean (SD) fasciculation severity/d, unita
 Placebo first 12 31.7 (26.7) 31.7 (29.0) −0.1 (8.5)
 Mexiletine first 8 25.8 (32.7) 32.4 (34.4) −6.6 (23.2)
a

Severity rated on the 100-unit visual analog scale.